Cargando…
Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi‐stakeholder, international workshop
BACKGROUND: It is increasingly common for two or more treatments for cancer to be combined as a single regimen. Determining value and appropriate payment for such regimens can be challenging. This study discusses these challenges, and possible solutions. METHODS: Stakeholders from around the world a...
Autores principales: | Latimer, Nicholas. R, Pollard, Daniel, Towse, Adrian, Henshall, Chris, Sansom, Lloyd, Ward, Robyn L, Bruce, Andrew, Deakin, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091555/ https://www.ncbi.nlm.nih.gov/pubmed/33941174 http://dx.doi.org/10.1186/s12913-021-06425-0 |
Ejemplares similares
-
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
por: Towse, Adrian, et al.
Publicado: (2021) -
Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB
por: Chalkidou, Kalipso, et al.
Publicado: (2020) -
Implementation of the polluter pay’s principle in tobacco control in the UK: a stakeholder analysis
por: Smith, Marissa J., et al.
Publicado: (2023) -
Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision Oncology
por: Pollard, Samantha, et al.
Publicado: (2022) -
Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China
por: Huang, Li, et al.
Publicado: (2023)